NCT00120939View on ClinicalTrials.gov

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

Not specified

Conditions
Breast NeoplasmsOvarian NeoplasmsProstatic NeoplasmsLung NeoplasmsGastrointestinal Neoplasms
Interventions
DRUG

Motexafin Gadolinium

Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY

NCT00120939 - Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | Biotech Hunter | Biotech Hunter